Literature DB >> 23947975

Italian population-based values of EQ-5D health states.

Luciana Scalone1, Paolo A Cortesi, Roberta Ciampichini, Andrea Belisari, Lucia S D'Angiolella, Giancarlo Cesana, Lorenzo G Mantovani.   

Abstract

OBJECTIVE: To estimate a value set for the calculation of Italian-specific quality-adjusted life years (QALYs), based on preferences elicited on EuroQol five-dimensional (EQ-5D) questionnaire health states using the time trade-off technique.
METHODS: The revised standard Measurement and Valuation of Health protocol was followed. Twenty-five health states, divided into three groups and given to 450 subjects, were selected to obtain 300 observations per state. Subjects aged 18 to 75 years were recruited to be representative of the Italian general adult population for age, sex, and geographical distribution. To improve efficiency, face-to-face interviews were conducted by using the Computer Assisted Personal Interviewing approach. Several random effects regression models were tested to predict the full set of EQ-5D questionnaire health states. Model selection was based on logical consistency of the estimates, sign and magnitude of the regression coefficients, goodness of fit, and parsimony.
RESULTS: The model that satisfied the criteria of logical consistency and was more efficient includes 10 main effect dummy variables for the EQ-5D questionnaire domain levels and the D1 interaction term, which accounts for the number of dimensions at levels 2 or 3 beyond the first. This model has an R(2) of 0.389 and a mean absolute error of 0.03, which are comparable to or better than those of models used in other countries. The utility estimates after state 11111 range from 0.92 (21111) to -0.38 (33333). Italian utility estimates are higher than those estimated in the United Kingdom and Spain and used so far to assess QALYs and conduct cost-utility evaluations in Italy.
CONCLUSIONS: A specific value set is now available to calculate QALYs for the conduction of health economic studies targeted at the Italian health care system.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D; cost-utility analysis; health-related quality of life; quality-adjusted life years; time trade-off

Mesh:

Year:  2013        PMID: 23947975     DOI: 10.1016/j.jval.2013.04.008

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  47 in total

1.  Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Authors:  Silvana Leo; Ermenegildo Arnoldi; Lazzaro Repetto; Zaira Coccorullo; Saverio Cinieri; Palma Fedele; Marina Cazzaniga; Vito Lorusso; Agnese Latorre; Giovanna Campanella; Mariangela Ciccarese; Caterina Accettura; Salvatore Pisconti; Antonio Rinaldi; Cosimo Brunetti; Mimma Raffaele; Luigi Coltelli; Salvatore Spazzapan; Lucia Fratino; Luciana Petrucelli; Laura Biganzoli
Journal:  Oncologist       Date:  2018-11-09

2.  Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.

Authors:  P A Cortesi; A Ciaccio; M Rota; J K Lim; S De Salvia; S Okolicsanyi; M Vinci; L S Belli; L G Mantovani; M Strazzabosco
Journal:  J Viral Hepat       Date:  2014-07-10       Impact factor: 3.728

3.  The impact of low back pain on health-related quality of life in old age: results from a survey of a large sample of Swiss elders living in the community.

Authors:  C Ludwig; C Luthy; A F Allaz; F R Herrmann; C Cedraschi
Journal:  Eur Spine J       Date:  2017-12-15       Impact factor: 3.134

4.  Quality of Life for Patients With Incurable Stage IV Colorectal Cancer: Randomized Controlled Trial Comparing Resection Versus Endoscopic Stenting.

Authors:  Enrico Fiori; Antonietta Lamazza; Antonio V Sterpetti; Daniele Crocetti; Francesca DE Felice; Marco DI Muzio; Andrea Mingoli; Paolo Sapienza; Giorgio DE Toma
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

5.  Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe.

Authors:  Karine Chevreul; Coralie Gandré; Karen Berg Brigham; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; László Gulácsi; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Ulf Persson; Giovani Fattore
Journal:  Eur J Health Econ       Date:  2016-04-12

6.  Palliative Surgery or Metallic Stent Positioning for Advanced Gastric Cancer: Differences in QOL.

Authors:  Enrico Fiori; Daniele Crocetti; Paolo Sapienza; Roberto Cirocchi; Antonio V Sterpetti; Michelangelo Miccini; Marcello Accordino; Silvano Costi; Pierfrancesco Lapolla; Andrea Mingoli; Giorgio De Toma; Antonietta Lamazza
Journal:  Medicina (Kaunas)       Date:  2021-04-28       Impact factor: 2.430

7.  Results from an exploratory study to test the performance of EQ-5D-3L valuation subsets based on orthogonal designs, and an investigation into some modeling and transformation alternatives for the utility function.

Authors:  Henry Bailey; Paul Kind; Althea La Foucade
Journal:  Health Econ Rev       Date:  2014-11-08

8.  The societal burden of chronic liver diseases: results from the COME study.

Authors:  Luciana Scalone; Stefano Fagiuoli; Roberta Ciampichini; Ivan Gardini; Raffaele Bruno; Luisa Pasulo; Maria Grazia Lucà; Francesco Fusco; Laura Gaeta; Anna Del Prete; Giancarlo Cesana; Lorenzo Giovanni Mantovani
Journal:  BMJ Open Gastroenterol       Date:  2015-03-30

9.  Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.

Authors:  Fausto Salaffi; Alessandro Ciapetti; Marina Carotti; Stefania Gasparini; Gustavo Citera; Marwin Gutierrez
Journal:  Health Qual Life Outcomes       Date:  2014-08-22       Impact factor: 3.186

10.  Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.

Authors:  Marco Di Carlo; Valentina Lato; Marina Carotti; Fausto Salaffi
Journal:  Health Qual Life Outcomes       Date:  2016-05-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.